LPL Financial’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Buy |
12,735
+3,854
| +43% | +$125K | ﹤0.01% | 4450 |
|
|
2025
Q1 | $335K | Buy |
8,881
+2,318
| +35% | +$87.5K | ﹤0.01% | 4408 |
|
|
2024
Q4 | $537K | Sell |
6,563
-6,902
| -51% | -$565K | ﹤0.01% | 3978 |
|
|
2024
Q3 | $1.54M | Buy |
13,465
+3,947
| +41% | +$451K | ﹤0.01% | 2944 |
|
|
2024
Q2 | $719K | Buy |
9,518
+956
| +11% | +$72.2K | ﹤0.01% | 3505 |
|
|
2024
Q1 | $585K | Sell |
8,562
-2,202
| -20% | -$150K | ﹤0.01% | 3603 |
|
|
2023
Q4 | $676K | Buy |
10,764
+1,139
| +12% | +$71.5K | ﹤0.01% | 3370 |
|
|
2023
Q3 | $491K | Buy |
9,625
+1,027
| +12% | +$52.4K | ﹤0.01% | 3474 |
|
|
2023
Q2 | $429K | Buy |
+8,598
| New | +$429K | ﹤0.01% | 3532 |
|